Besides, how do you treat relapsed/refractory diffuse large B cell lymphoma?
Salvage high-dose chemotherapy followed by autologous stem cell transplantation is the standard of care for chemosensitive relapses in DLBCL. Various salvage regimens are available, but the quest for an optimal regimen continues. The addition of rituximab to the salvage regimen has improved the outcome of RR DLBCL.
Secondly, what is refractory lymphoma? Refractory non-Hodgkin lymphoma (NHL) is NHL that has not responded to initial treatment. Refractory disease may be disease that is getting worse or staying the same. Relapsed non-Hodgkin lymphoma (NHL) is NHL that responded to treatment but then returns.
Then, what is the survival rate for diffuse B cell lymphoma?
Diffuse large B cell lymphoma (DLBCL) is the commonest subtype of non-Hodgkin's lymphoma accounting for approximately 30–50 % of cases [1]. DLBCL shows an aggressive behavior with a median survival of less than 1 year in untreated patients.
Is diffuse large B cell lymphoma curable?
In the United States, DLBCL affects about 7 out of 100,000 people each year. DLBCL is a fast-growing, aggressive form of NHL. DLBCL is fatal if left untreated, but with timely and appropriate treatment, approximately two-thirds of all people can be cured.
